- Home
- CNTB vs DRIO Comparison
CNTB vs DRIO Comparison
Compare CNTB & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTB
- DRIO
- Stock Information
- Founded
- CNTB 2012
- DRIO 2011
- Country
- CNTB United States
- DRIO United States
- Employees
- CNTB N/A
- DRIO N/A
- Industry
- CNTB Biotechnology: Pharmaceutical Preparations
- DRIO Medical/Dental Instruments
- Sector
- CNTB Health Care
- DRIO Health Care
- Exchange
- CNTB Nasdaq
- DRIO Nasdaq
- Market Cap
- CNTB 94.2M
- DRIO 87.0M
- IPO Year
- CNTB 2021
- DRIO N/A
- Fundamental
- Price
- CNTB $1.59
- DRIO $15.33
- Analyst Decision
- CNTB Strong Buy
- DRIO Strong Buy
- Analyst Count
- CNTB 2
- DRIO 2
- Target Price
- CNTB $7.50
- DRIO $50.00
- AVG Volume (30 Days)
- CNTB 79.5K
- DRIO 36.4K
- Earning Date
- CNTB 11-30-2025
- DRIO 11-06-2025
- Dividend Yield
- CNTB N/A
- DRIO N/A
- EPS Growth
- CNTB N/A
- DRIO N/A
- EPS
- CNTB N/A
- DRIO N/A
- Revenue
- CNTB $1,965,000.00
- DRIO $27,148,000.00
- Revenue This Year
- CNTB N/A
- DRIO N/A
- Revenue Next Year
- CNTB $453,067.90
- DRIO $59.84
- P/E Ratio
- CNTB N/A
- DRIO N/A
- Revenue Growth
- CNTB N/A
- DRIO 41.79
- 52 Week Low
- CNTB $1.23
- DRIO $5.94
- 52 Week High
- CNTB $2.20
- DRIO $31.00
- Technical
- Relative Strength Index (RSI)
- CNTB 45.14
- DRIO 57.73
- Support Level
- CNTB $1.50
- DRIO $14.82
- Resistance Level
- CNTB $1.72
- DRIO $16.44
- Average True Range (ATR)
- CNTB 0.13
- DRIO 1.18
- MACD
- CNTB -0.02
- DRIO -0.28
- Stochastic Oscillator
- CNTB 18.00
- DRIO 71.82
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.
About DRIO DarioHealth Corp.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.